Infect Immun. 1992 Jun;60(6):2547-50.

Early complement components enhance neutralization of Chlamydia trachomatis infectivity by human sera.

Source

Maxwell Finland Laboratory, Boston City Hospital, Massachusetts.

Abstract

Immunoglobulin G in human serum neutralizes chlamydial infectivity in vitro. Complement-intact, C5-depleted, and C8-depleted human serum all have significantly more neutralizing activity than serum heated to inactivate early components of complement. Cobra venom factor, an analog of human C3b, enhances neutralization of antichlamydial immunoglobulin G in the absence of early complement components.

PMID:: 1587622; [PubMed - indexed for MEDLINE]
PMCID:: PMC257196

Free PMC Article

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

Research Support, U.S. Gov't, P.H.S.

MeSH Terms

Substances

Grant Support

1 POI 24760/PHS HHS/United States

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Save items

Related citations in PubMed

Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis. [Infect Immun. 1993]
Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis.
Peterson EM, Cheng X, Pal S, de la Maza LM. Infect Immun. 1993 Feb; 61(2):498-503.
Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection. [Infect Immun. 1997]
Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.
Peterson EM, Cheng X, Motin VL, de la Maza LM. Infect Immun. 1997 Jul; 65(7):2693-9.
Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex. [J Immunol. 1991]
Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
Kochi SK, Johnson RC, Dalmasso AP. J Immunol. 1991 Jun 1; 146(11):3964-70.
Review Recombinant cobra venom factor. [Mol Immunol. 2004]
Review Recombinant cobra venom factor.
Vogel CW, Fritzinger DC, Hew BE, Thorne M, Bammert H. Mol Immunol. 2004 Jun; 41(2-3):191-9.
Review Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion. [Curr Pharm Des. 2007]
Review Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion.
Vogel CW, Fritzinger DC. Curr Pharm Des. 2007; 13(28):2916-26.

See reviews... See all...

Cited by 4 PubMed Central articles

Chlamydia infection status, genotype, and age-related macular degeneration. [Mol Vis. 2012]
Chlamydia infection status, genotype, and age-related macular degeneration.
Khandhadia S, Foster S, Cree A, Griffiths H, Osmond C, Goverdhan S, Lotery A. Mol Vis. 2012; 18:29-37. Epub 2012 Jan 10.
Native properdin binds to Chlamydia pneumoniae and promotes complement activation. [Infect Immun. 2011]
Native properdin binds to Chlamydia pneumoniae and promotes complement activation.
Cortes C, Ferreira VP, Pangburn MK. Infect Immun. 2011 Feb; 79(2):724-31. Epub 2010 Dec 6.
Review Killing me softly: chlamydial use of proteolysis for evading host defenses. [Trends Microbiol. 2009]
Review Killing me softly: chlamydial use of proteolysis for evading host defenses.
Zhong G. Trends Microbiol. 2009 Oct; 17(10):467-74. Epub 2009 Sep 16.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Early complement components enhance neutralization of Chlamydia trachomatis infe...
Early complement components enhance neutralization of Chlamydia trachomatis infectivity by human sera.
Infect Immun. 1992 Jun ;60(6):2547-50.

PubMed
Using surveys in public participation processes for risk decision making: the ca...
Using surveys in public participation processes for risk decision making: the case of the 2003 British GM Nation? Public debate.
Risk Anal. 2005 Apr ;25(2):467-79.

PubMed
Regulation of ribosomal protein synthesis in Escherichia coli by selective mRNA ...
Regulation of ribosomal protein synthesis in Escherichia coli by selective mRNA inactivation.
Proc Natl Acad Sci U S A. 1979 Jul ;76(7):3411-5.

PubMed
Mercury levels in urine and hair of children in an Andean gold-mining settlement...
Mercury levels in urine and hair of children in an Andean gold-mining settlement.
Int J Occup Environ Health. 2005 Apr-Jun ;11(2):132-7.

PubMed
Mucosal immunity: implications for vaccine development.
Mucosal immunity: implications for vaccine development.
Immunobiology. 1992 Feb ;184(2-3):157-79.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: